PT  - JOURNAL ARTICLE
AU  - Wei, Wei
AU  - Ban, Xiaohua
AU  - Yang, Fan
AU  - Li, Jibin
AU  - Cheng, Xiaqin
AU  - Zhang, Rong
AU  - Huang, Xin
AU  - Huang, Yongwen
AU  - Li, Qiaqia
AU  - Qiu, Ya
AU  - Zheng, Min
AU  - Zhu, Xiaofeng
AU  - Li, Jundong
TI  - Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
AID  - 10.1136/jitc-2021-004338
DP  - 2022 May 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004338
VI  - 10
IP  - 5
4099  - http://jitc.bmj.com/content/10/5/e004338.short
4100  - http://jitc.bmj.com/content/10/5/e004338.full
SO  - J Immunother Cancer2022 May 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.